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The study of 5-hydroxylmethylcytosines (5hmC) has
been hampered by the lack of a method to map it
at single-base resolution on a genome-wide scale.
Affinity purification-based methods cannot precisely
locate 5hmC nor accurately determine its relative
abundance at each modified site. We here present
a genome-wide approach, Tet-assisted bisulfite
sequencing (TAB-Seq), that when combined with
traditional bisulfite sequencing can be used for
mapping 5hmC at base resolution and quantifying
the relative abundance of 5hmC as well as 5mC.
Application of this method to embryonic stem cells
not only confirms widespread distribution of 5hmC
in themammalian genome but also reveals sequence
bias and strand asymmetry at 5hmC sites. We
observe high levels of 5hmC and reciprocally low
levels of 5mC near but not on transcription factor-
binding sites. Additionally, the relative abundance
of 5hmC varies significantly among distinct func-
tional sequence elements, suggesting different
mechanisms for 5hmC deposition and maintenance.
INTRODUCTION
5-methylcytosine (5mC) in mammalian genomic DNA is essential
for normal development and impacts a variety of biological func-
tions. In 2009, 5-hydroxymethylcytosine (5hmC) was discovered
as another relatively abundant form of cytosine modification in
embryonic stem cells (ESCs) and Purkinje neurons (Kriaucionis
and Heintz, 2009; Tahiliani et al., 2009). The TET proteins, which
are responsible for conversionof 5mC to5hmC,havebeenshown
to function in ESC regulation, myelopoiesis, and zygote develop-
ment (Dawlaty et al., 2011; Gu et al., 2011; Iqbal et al., 2011; Ito
et al., 2010; Ko et al., 2010; Koh et al., 2011; Wossidlo et al.,1368 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.2011). 5hmC was found to be widespread in many tissues and
cell types, although with diverse levels of abundance (Globisch
et al., 2010; Mu¨nzel et al., 2010; Song et al., 2011; Szwagierczak
et al., 2010). Proteins that can recognize 5hmC-containing DNA
have also been investigated (Frauer et al., 2011; Yildirim et al.,
2011). In addition, 5hmC can be further oxidized to 5-formylcyto-
sine (5fC) and 5-carboxylcytosine (5caC) by TET proteins (He
etal., 2011; Itoet al., 2011;Pfaffenederet al., 2011), anddemethy-
lation pathways through these modified cytosines have been
shown (Cortellino et al., 2011; Guo et al., 2011; He et al., 2011;
Maiti and Drohat, 2011; Zhang et al., 2012). Together, these
studies provide an emerging paradigm in which 5mC oxidation
plays important roles in sculpting a cell’s epigenetic landscape
and developmental potential through the regulation of dynamic
DNA methylation states.
Strategies to label and/or enrich 5hmC in genomic DNA have
been developed to investigate the distribution and function of
5hmC in the genome (Ficz et al., 2011; Pastor et al., 2011; Rob-
ertson et al., 2011, 2012; Song et al., 2011; Stroud et al., 2011;
Williams et al., 2011; Wu et al., 2011; Xu et al., 2011). Although
5hmC ismore enriched in gene bodies than transcription starting
sites in mouse cerebellum (Song et al., 2011; Szulwach et al.,
2011b), all genome-wide maps of 5hmC in human ESCs (hESCs)
and mouse ESCs (mESCs) indicate that 5hmC tends to exist in
gene bodies, promoters, and enhancers (Ficz et al., 2011; Pastor
et al., 2011; Stroud et al., 2011; Szulwach et al., 2011a; Williams
et al., 2011; Wu et al., 2011; Xu et al., 2011). However, in all
cases, the resolution of these maps was restricted by the size
of the immunoprecipitated or chemically captured DNA, which
varied from several hundred to over a thousand bases.
The study of 5mC has been facilitated by the development of
whole-genome bisulfite sequencing methods that can resolve
the genomic location of methylcytosine at single-base resolution
(Cokus et al., 2008; Lister et al., 2008, 2009). However, current
bisulfite sequencing methods cannot distinguish between 5mC
and 5hmC (Huang et al., 2010; Jin et al., 2010). Therefore, the
genome-wide bisulfite sequencing maps generated in recent
years may not accurately capture the true abundance of 5mC
at each base in the genome. A more detailed understanding of
the function of 5hmC as well as 5mC has, therefore, been
hampered by the lack of a single-base resolution sequencing
technology capable of detecting the relative abundance of
5hmC per cytosine.
Here we present a Tet-assisted bisulfite sequencing (TAB-
Seq) strategy, which provides a method for single-base resolu-
tion detection of 5hmC amenable to both genome-wide and
loci-specific sequencing. Applying this method, we have gener-
ated genome-wide, single-base resolution maps of 5hmC in
ESCs. Distinct classes of functional elements exhibit variable
abundance of 5hmC, with promoter-distal regulatory elements
harboring the highest levels of 5hmC. High levels of 5hmC
and reciprocally low levels of 5mC can be found near binding
sites of transcription factors. In contrast to 5mC, 5hmC sites
display strand asymmetry and sequence bias. Finally, the
base-resolutionmaps of 5hmC providemore accurate estimates
of both 5hmC and 5mC levels at each modified cytosine than
previous whole-genome bisulfite sequencing approaches. Our
results support a dynamic DNA methylation process at distal-
regulatory elements and suggest that different mechanisms of
DNA modification may be involved at distinct classes of func-
tional sequences in the genome.
RESULTS
TAB-Seq of Model DNA and Specific Loci
Traditional bisulfite sequencing cannot discriminate 5mC from
5hmC because both resist deamination by bisulfite treatment
(Huang et al., 2010; Jin et al., 2010). We have recently found
that TET proteins not only oxidize 5mC to 5hmC but also
further oxidize 5hmC to 5caC, and that 5caC exhibits behavior
similar to that of unmodified cytosine after bisulfite treatment
(He et al., 2011; Ito et al., 2011). This deamination difference
between 5caC and 5mC/5hmC under standard bisulfite condi-
tions inspired us to explore TAB-Seq. In this approach, we
use b-glucosyltransferase (bGT) to introduce a glucose onto
5hmC, generating b-glucosyl-5-hydroxymethylcytosine (5gmC)
to protect 5hmC from further TET oxidation. After blocking of
5hmC, all 5mC is converted to 5caC by oxidation with an excess
of recombinant Tet1 protein. Bisulfite treatment of the resulting
DNA then converts all C and 5caC (derived from 5mC) to uracil
or 5caU, respectively, whereas the original 5hmC bases remain
protected as 5gmC. Thus, subsequent sequencing will reveal
5hmC as C, which, when combined with traditional bisulfite
sequencing results, will provide an accurate assessment of
abundance of this modification at each cytosine (Figure 1A).
We first confirmed that 5gmC is read as C in traditional bisulfite
sequencing (data not shown). We cloned and expressed the
catalytic domain of mouse Tet1 (mTet1) (Figure S1A available
online), as previously reported (Ito et al., 2010). We tested a
double-stranded DNA (dsDNA) with site-specifically incorpo-
rated 5mC or 5hmC modification (Figure 1B). Application of
our method with Sanger sequencing of the PCR-amplified prod-
ucts showed that the original 5mC was completely converted
into T after treatment, indicating efficient oxidation of 5mC to
5caC by mTet1 (Figure 1B). However, the original 5hmC was
sequenced as C, confirming that the protected 5gmC is resistantto deamination under bisulfite treatment (Figure 1B). The prod-
ucts of each step were confirmed by MALDI-TOF/TOF using
a shorter model duplex DNA (Figure 1C). Full conversion of
5mC in the context of genomic DNA was also confirmed by
conventional bisulfite, PCR, and both Sanger and semicon-
ductor sequencing (Figures S1B and S1C). Additionally, applica-
tion to genomic DNA confirmed conversion of 5mC to 5caC and
protection of 5hmC, and that 5fC is undetectable by immunoblot
on the final reaction products (Figure 1D). Thus, coupling bGT-
mediated transfer of glucose to 5hmC with mTet1-catalyzed
oxidation of 5mC to 5caC enables the distinction of 5hmC from
both C and 5mC after sodium bisulfite treatment.
The ability to distinguish 5hmC at base resolution offers
a significant opportunity to further parse DNA methylation/
hydroxymethylation states at specific genomic loci. We applied
traditional bisulfite sequencing and TAB-Seq to known 5hmC-
enriched loci in mouse cerebellum that were identified previously
(Song et al., 2011; Szulwach et al., 2011b). Comparing the
sequencing results, we were able to identify genuine 5hmC
and 5mC sites (Figure S1D).
Generation of Base-Resolution Maps of 5hmC in ESCs
We next applied TAB-Seq to genomic DNA from H1 hESCs
and E14Tg2a mESCs and sequenced to an average depth of
26.53 and 173 per cytosine, respectively. Successful detection
of 5hmC is governed by three key parameters: (1) efficient
conversion of unmodified cytosine to uracil; (2) efficient conver-
sion of 5mC to 5caU/U; and (3) efficient protection of 5hmC. To
directly assess these conversion rates in the context of genomic
DNA, sequenced samples were spiked in with fragments of
lambda DNA amplified by PCR to contain three distinct domains
having either unmodified cytosine, 5mC, or 5hmC. We observe
low nonconversion rates for unmodified cytosine (0.38%) and
5mC (2.21%), contrasted to a high nonconversion rate of
5hmC (84.4%) (Figure S2B). Further analysis indicates that this
latter value is an underestimate of the true 5hmC protection
rate in H1, which is close to 92.0% (Figures S2D and S2E). These
data further confirm the capability of TAB-Seq for robust distinc-
tion of 5hmC from 5mCand unmodified cytosine in the context of
genomic DNA.
We next focused our analysis on the map of H1 hESCs.
To confidently identify 5hmC-modified bases, we took advan-
tage of the highly annotated H1 methylome generated with
methylC-Seq, which identifies both 5mC as well as 5hmC.
Accordingly, we restricted our search for 5hmC to the subset
of methylated bases previously identified bymethylC-Seq (Lister
et al., 2009). The probability that a cytosine can be confidently
identified as 5hmC is governed by the sequencing depth at the
cytosine and abundance of the modification (Figure S2C).
Modeling this probabilistic event with a binomial distribution
(Lister et al., 2009) withN as the depth of sequencing at the cyto-
sine and p as the 5mCnonconversion rate, we identified a total of
691,414 5hmCs with a false discovery rate of 5% (Figure S2F;
see Extended Experimental Procedures). Given an average
sequencing depth of 26.5, our assay can on average resolve
5hmC having an abundance of 20% or higher (Figure S2C).
Genomic profiles of absolute 5hmC levels are comparable to
a map previously generated with an affinity-based approachCell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc. 1369
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Figure 1. TAB-Seq Strategy and Validation
(A) Schematic diagram of TAB-Seq. 5hmCs in genomic DNA are protected by glucosylation, and then 5mCs are converted to 5caCs by Tet-mediated oxidation.
After bisulfite treatment, both 5caC (generated from 5mC) and C display as T, whereas 5gmC (generated from original 5hmC) displays as C.
(B) TAB-Seq of 76-mer dsDNA with 5mC or 5hmC. The 76-mer dsDNA with 5mC (left) or 5hmC (right) modification was subject to TAB-Seq as described in (A).
Sanger sequencing results showed that 5mC was completely converted to T (left) and 5hmC was still read as C (right).
(C) Mass spectrometry characterization of the products from TAB-Seq with a model DNA. The dsDNA contains a 5mC (left) or 5hmC (right) on a 9-mer strand
annealed to a 11-mer complementary strand. The DNA was subject to bGT-mediated glucosylation and mTet1-mediated oxidation. The reactions were moni-
tored by MALDI-TOF/TOF with the calculated and observed molecular weight indicated.
1370 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.
AC D E
B
Figure 2. Generation of Genome-wide Base-Resolution Maps of 5hmC
(A) Snapshot of base-resolution 5hmC maps (red) compared to affinity-based 5hmC maps (gray) in H1 cells near the POU5F1 gene. Also shown are base-
resolution maps of traditional bisulfite sequencing in H1 cells (black/gray). Positive values (darker shades) indicate cytosines on the Watson strand, whereas
negative values (lighter shades) indicate cytosines on the Crick strand. For 5hmC, the vertical axis limits are50% to +50%. For traditional bisulfite sequencing,
the limits are 100% to +100%. Only cytosines sequenced to depthR 5 are shown.
(B) Overlap of 5hmCwith 82,221 genomic regions previously identified as enrichedwith 5hmCby affinitymapping (black), in comparison to randomly chosen 5mC
(white) (see Extended Experimental Procedures).
(C) Sequence context of 5hmC sites compared to the reference human genome.
(D) Heatmap of estimated abundances of 5hmC and 5mC for modified cytosines significantly enriched with 5hmC. 5mCwas estimated as the rate from traditional
bisulfite sequencing (5hmC + 5mC) minus the measured 5hmC rate.
(E) The distribution of estimated abundances of 5hmC (red) and 5mC (green) at 5hmC sites. m: median.
Error bars indicate standard deviation (SD). See also Figure S2.(Szulwach et al., 2011a) (Figure 2A). As sequenced fragments are
equally distributed among the population of cells, TAB-
Seq provides a steady-state glimpse of 5hmC in the entire
population. This is in contrast to affinity-based approaches,
which bias sequencing toward 5hmC-enriched DNA fragments.
By TAB-Seq, identified 5hmCs are highly clustered, unlike
5mCs (Figure S3A), and track well with peaks of 5hmC enrich-
ment previously identified by affinity sequencing (Figure 2A).
There are 7.6 times as many 5hmCs overlapping affinity-identi-
fied regions as expected by chance (Figure 2B, Z-score =(D) Validation with western blotting of 5mC and 5hmC conversion in genomic DN
DNAwere tested with dot blot assays using antibodies against 5mC, 5hmC, 5fC, a
all 5mCs were converted into 5caCs after the mTet1-mediated oxidation.
See also Figure S1.1,579). Furthermore, 81.5% of these 82,221 affinity-identified
regions were recovered by at least one 5hmC. In contrast,
only 35.6% of 5hmCs are recovered by affinity-based
approaches, suggesting an increased sensitivity of TAB-Seq.
Using semiconductor sequencing, we verified the presence/
absence of 5hmC at 57 out of 59 individual cytosines (9 out of
11 hydroxymethylated CpGs, with depth R 30) within regions
that previously escaped detection by 5hmC affinity capture (Fig-
ure S2A), underscoring the sensitivity and specificity of our
approach.A (mouse ES). The untreated DNA, bGT-treated DNA, and bGT/mTet1-treated
nd 5caC, respectively. No 5hmC could be observed after glucosylation. Almost
Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc. 1371
Application of TAB-Seq to mESCs resulted in 2,057,636 high-
confidence 5hmCs. This larger number of sites is likely attribut-
able to higher-level expression of both Tet1 and Tet2 in mESCs
as revealed by RNA-Seq analysis (Lister et al., 2011; Myers et al.,
2011) (B.R., unpublished data). Like H1, these 5hmCs are also
significantly enriched at genomic loci recovered by affinity
sequencing (Figure S2J). In addition, these 5hmC sites are signif-
icantly enriched for previously mapped binding sites of Tet1
(Williams et al., 2011; Wu et al., 2011), confirming the TAB-Seq
approach.
Base Composition and Genomic Distribution of 5hmC
DNAmethylation of cytosines can exist in several contexts: CpG
(denoted CG), CHG, and CHH (H = A, C, or T). Although it has
been suggested that mESCs may harbor 5hmC in non-CG
context (Ficz et al., 2011) and although non-CG methylation is
present in human and mESCs (Lister et al., 2009; Stadler et al.,
2011), we found that nearly all (99.89%) of H1 5hmCs exist in
the CG context (Figure 2C). Similarly, this figure is 98.7% in
mESCs (Figure S2G).
The combination of traditional methylC-Seq and TAB-Seq
maps allows us to estimate the true abundance of both 5hmC
and 5mC. We observe that, in a steady-state population of cells,
5mC and 5hmC often coexist at the same cytosine (Figure 2D).
The median observed abundance of 5hmC at 5hmC-rich cyto-
sines is 19.2%, compared to 60.7% for 5mC as estimated
from traditional bisulfite sequencing (Figure 2E). Adjusting for
the 92.0% protection rate of 5hmC by TAB-Seq, we estimate
the corrected median 5hmC and 5mC abundance to be 20.9%
and 59.0%, respectively. These results suggest that, at the
base level, the abundance of 5hmC is lower than that of 5mC.
This observation is corroborated in mESCs (Figures S2H and
S2I) and is consistent with a previous estimate of global 5hmC
levels in ESCs (Tahiliani et al., 2009).
Previous studies using affinity-based approaches have
demonstrated that 5hmC is enriched at promoters, enhancers,
CTCF-binding sites, exons, and gene bodies (Ficz et al., 2011;
Pastor et al., 2011; Stroud et al., 2011; Szulwach et al., 2011a;
Williams et al., 2011; Wu et al., 2011; Xu et al., 2011), suggesting
an extensive role for this modification in gene regulation. Sup-
porting a functional role of 5hmC, we observe a trend of
increasing sequence conservation for increasing abundance
of 5hmC (Figure S3B). However, the absolute abundance of
5hmC cannot be assessed from affinity-based detection
methods, therefore precluding further quantitative analysis
of 5hmC’s role at each class of regulatory elements. In H1,
we found that almost half (46.4%) of the 5hmCs reside in
distal-regulatory elements mapped by ChIP-Seq and DNase-
Seq (Figure 3A). Assessing relative enrichment of 5hmC at
each class of regulatory element by normalizing with genomic
coverage, H1 distal-regulatory elements including p300-binding
sites (observed/expected [o/e] = 7.6), predicted enhancers
(o/e = 7.8), CTCF-binding sites (o/e = 5.1), and DNase I hyper-
sensitive sites (o/e = 3.4) are more enriched with 5hmC than
with other genic regions (Figure 3B). Intriguingly, the subset of
cytosines showing nearly equal levels of 5mC and 5hmC are
more enriched in distal-regulatory elements and less enriched
at promoters and genic features (Figure S3E), suggesting that1372 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.active demethylation is strongest outside of genes. In support
of this observation, promoter-distal ChIP-Seq peaks for OCT4,
SOX2, NANOG, KLF4, and TAFII are also more enriched with
5hmC than with genic features (Figure S3D). Finally, we observe
that increasing DNase I hypersensitivity signal correlates well
with increased 5hmC and decreased 5mC enrichment (Fig-
ure S3C). These results are also supported by observations in
mESCs (Figures S3F and S3G), though we observe an increase
in intragenic 5hmC occupancy.
Examining only those genomic elements having significant
5hmC enrichment, we found that the absolute levels of 5hmC at
all classes of distal-regulatory elements are significantly higher
than those of promoter-proximal elements (Figure 3C). In
contrast, gene bodies with significant levels of 5hmC show
statistically lower levels of 5hmC. Furthermore, examining the
estimated level of 5mCat these loci, we observed an inverse rela-
tionship between 5mC and 5hmC (Figure 3C). Distal-regulatory
elementshave the lowest levels of 5mC,withp300andenhancers
having median abundances of 42.2% and 53.7%, respectively.
This suggests that highly demethylated elements such as
p300 contain more cytosines in a non-5mC/5hmC form, impli-
cating stronger demethylation at these regulatory elements.
In combination with the observations that (1) between 44%
and 74% of distal-regulatory elements are significantly enriched
with 5hmC in hESCs and mESCs (Figures 3D and S3H); (2) the
same class of elements are also enriched with hmC in mESCs
(Figures 3E and S3G); and (3) the sequence-conserved distal-
regulatory elements in H1 are conserved for 5hmC in mESCs
(Figure 3F), our data suggest that the marking of functional regu-
latory elements with 5hmC is an evolutionarily conserved
phenomenon with potential functional consequences. Together,
these data show that 5hmC is most abundant at promoter-distal
regulatory elements and particularly enriched in distal-regulatory
elements.
Besides distal-regulatory elements, we observe significant
enrichment of 5hmC at genes of all tiers, but lowly expressed
genesaremoreenrichedthanhighlyexpressedgenes (FigureS3I),
consistentwithprevious studies (Pastor et al., 2011). In contrast to
the abundant 5hmC found at regulatory elements in H1, the vast
majority of repetitive elements are highly enriched with 5mC
but not 5hmC (Figure S3J). Between 3.5% and 7.5% of repetitive
elements are significantly enriched with 5hmC, with long-terminal
repeats (LTRs) being the highest (Figure S3K). At these significant
loci, theabsoluteabundanceof5hmC isonparwithpromotersbut
less than distal-regulatory elements (Figure S3L).
Profiles of Hydroxymethylcytosine at Distal-Regulatory
Elements
5mC is thought to confer specificity to gene regulation by influ-
encing transcription factor binding or serving as a substrate of
recognition for chromatin regulators (Bird, 2011; Chen and
Riggs, 2011; Jaenisch and Bird, 2003; Quenneville et al., 2011).
Similarly, it has been suggested that 5hmC offers a different plat-
form upon which transcription factors may bind or 5mC-specific
binding proteins may be excluded (Hashimoto et al., 2012;
Kriaucionis and Heintz, 2009; Valinluck et al., 2004; Yildirim
et al., 2011). As 5hmC is enriched near enhancers, one possibility
is that this modified base is specifically recognized by
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Figure 3. Genomic Distribution of 5hmC Sites
(A) Overlap of H1 5hmC with genomic elements. Genic features were extracted from the UCSC Known Genes database (Hsu et al., 2006). Promoter-distal
regulatory elements (>5 kb from TSS) reflect those experimentally mapped in H1 cells from ChIP-Seq and DNase-Seq experiments. Each 5hmC base is counted
once: the overlap of a genomic element excludes all previously overlapped cytosines counterclockwise to the arrow. Green: promoter-proximal elements; red:
promoter-distal regulatory elements; gray: genic regions; white: intergenic regions.
(B) The relative enrichment of H1 5hmC (black) and random sites (gray) at genomic elements, normalized to the total coverage of the element type. Random
consists of 10 random samplings of 5mC (see Extended Experimental Procedures).
(C) The levels of 5hmCG (left) and 5mCG (right) for several classes of genomic elements significantly enriched with 5hmCG in H1 (p = 0.01, binomial). The dotted
line indicates the 5mC nonconversion rate. Colors as in (A).
(D) The percentage of distal-regulatory elements significantly enriched with 5hmCG in H1.
(E) In mESCs, the absolute level of 5hmCG for several classes of genomic elements significantly enriched with 5hmCG (p = 0.01, Fisher’s exact test). Colors
as in (A).
(F) For genomic elements significantly enriched with 5hmCG in H1 ESCs and conserved in mouse, the distribution of 5hmCG in mESCs. Colors as in (A).
In all panels, definitions of enhancers, p300, CTCF, and DNase I sites are promoter distal (>5 kb from TSS).
For boxplots, notches indicate median, boxes extend to the 25th and 75th percentiles, and whiskers extend to nonoutliers. Error bars indicate SD. See also
Figure S3.
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Figure 4. Profiles of 5hmC at Distal-
Regulatory Elements
(A) Frequency of 5hmC around distal p300-binding
sites.
(B) Absolute levels of 5hmCG (red) and 5mCG +
5hmCG (black) around the distal p300-binding
sites containing an OCT4/SOX2/TCF4/NANOG
motif (blue bar, center; consensus: ATTTGCATA
ACAATG). 5mC (green) was estimated as the rate
from traditional bisulfite sequencing (5hmC +
5mC) minus the measured 5hmC rate. The top half
indicates enrichment on the strand containing the
motif, with the bottom half indicating the opposite
strand.
(C)Frequencyof5hmCarounddistalCTCF-binding
sites, relative to the CTCFmotif (blue bar, bottom).
The different lines represent different strands,
oriented with respect to the CTCF motif
(consensus:ATAGTGCCACCTGGTGGCCA).Opp,
opposite.
(D) Absolute levels of 5hmCG, 5mCG, and
5mCG + 5hmCG around distal CTCF-binding sites
anchored at the CTCF motif (blue bar, center).
Colors as in (B).
See also Figure S4.transcription factors as a core base in binding motifs. But as
sequence motifs are typically shorter than 20 bp, the resolution
of affinity-based approaches is not sufficient to resolve whether
5hmC is actually present within or outside of the binding site. We
observed that whereas 5hmC is abundant within 500 bp of distal
p300-binding sites, there is a local depletion near the expected
transcription factor-binding site (Figures 4A and S4A). To
increase resolution, we anchored p300 binding with the OCT4/
SOX2/TCF4/NANOG consensus motif (Lister et al., 2009). Total
DNA methylation (5mC + 5hmC) decreases toward the motif, in
agreement with a recent study (Stadler et al., 2011), whereas
5hmC displays a bimodal peak of enrichment centered at the
motif with a maximum average abundance of 12.3% (Figure 4B).
Similarly, for CTCF-binding sites, we observed a bimodal
enrichment profile of 5hmC abundance 150 bp around the
motif, with almost no 5hmC within the motif itself (Figure 4C).
5hmC increases to a maximum abundance of 13.4%, coinciding
with a dramatic depletion of 5mC from an average high of 86.2%
to a low of 21.0% (Figure 3D). We also observed similar results
for NANOG-binding sites (Figures S4B and S4C). Together,
these data suggest that 5hmC is typically not observed within
potential binding sites of transcription factors but rather is
most enriched in regions immediately adjacent to sequence
motifs. The reciprocal profiles of 5hmC and 5mC are consistent
with a model of dynamic DNAmethylation associated with DNA-
binding transcription factors and provide additional evidence
supporting a role for 5hmC in the locally reduced levels of 5mC
at distal-regulatory elements (Stadler et al., 2011).
Asymmetric Hydroxymethylation at CG Sequences
Cytosine methylation in CG context is symmetric, and the main-
tenancemethyltransferaseDNMT1ensures efficient propagation1374 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.of symmetric 5mCGduring cell division, thus providing one of the
central modes of epigenetic inheritance (Bird, 2011; Chen and
Riggs, 2011; Goll and Bestor, 2005; Jaenisch and Bird, 2003;
Wigler et al., 1981). Our observation that the bimodal distribution
of 5hmC around CTCF is strand asymmetric (Figures 4C and 4D)
prompted us to examine whether 5hmC is strand biased in H1.
Whereas 91.8% of 5mCs are symmetrically modified, we found
that only 21.0% of 5hmCs are symmetric. However, because
the abundance of 5hmC is rare at any given cytosine (median
19.2%; Figure 2E), it is possible that sequencing depth was not
sufficient to identify all 5hmCs, making this an underestimate.
To address this issue, we compared the pool of all called
5hmCs with the pooled 5hmC content on the opposite cytosine
(Figure 5A). The average abundance of 5hmC is 20.0% at called
5hmCs, compared to 10.9% at the opposite cytosine, which
corresponds to an 83.8% enrichment of 5hmC (Figure 5B, p < 1
3 1015, binomial). As a control, the baseline 5hmC content of all
methylated cytosines in CG context is symmetric and compa-
rable to the methylcytosine nonconversion rate (Figure 5C). At
promoters and within gene bodies, we found that strand bias is
not dependent on the orientation of the transcript (Figure S5A)
(ppromoter = 0.0339, pgene body = 0.0719).
To confirm the asymmetry of 5hmCG, we examined the differ-
ence in methylation state of called 5hmCs and the cytosines
located at the opposite strands. From traditional bisulfite
sequencing, the median difference in total methylation
(5mCG + 5hmCG) between called and opposite cytosines is
0%. In contrast, TAB-Seq reveals a shifted distribution with
a median of 10.9% less hydroxymethylation on the opposite
cytosine (Figure 5D, p < 1 3 1015, Wilcoxon). Simultaneous
examination of the absolute levels of 5hmC on both called and
opposite cytosines showed that the shift in hydroxymethylation
AD E
B C
Figure 5. Asymmetry around 5hmCG
(A) A schematic of nomenclature. The cytosine with 5hmC (red) is designated as ‘‘called,’’ whereas the cytosine on the opposite strand (green) is designated as
‘‘opposite.’’
(B) The average 5hmC abundance of called 5hmCG residues (red) compared to the opposite cytosine residues (green). Called: called cytosine; opp: opposite
cytosine.
(C) The average 5hmC (black) and 5mC (white) abundance at called and opposite cytosines, for called cytosines having 5hmC (left) or 5mC + 5hmC (right). 5mC
(white excluding black) was estimated as the rate from traditional bisulfite sequencing (5hmC + 5mC) minus the measured 5hmC rate. Gray line: 5mC
nonconversion rate.
(D) The distribution of differences in 5hmCG (red) between called and opposite cytosines, in comparison to differences observed from traditional bisulfite
sequencing (green, 5mCG + 5hmCG). Called and opposite cytosines are each sequenced to at least depth 10.
(E) For 5hmC-called sites, a heatmap of 5hmCG abundance at called and opposite cytosine pairs (left). For the 5mC-called sites from traditional bisulfite
sequencing, a heatmap of 5mCG + 5hmCG abundance at called and opposite cytosine pairs (right) is shown.
See also Figure S5.state toward the called cytosine is evident, in contrast to DNA
methylation levels that remain symmetric (Figure 5E). Our anal-
ysis of the spike-in lambda DNA showed no strand nor sequence
bias of the TAB-Seqmethod (Figures S5B and S2D). This conclu-
sion was further supported by analyzing the bGT-catalyzed
glucosylation efficiency of a fully hydroxymethylated model
dsDNA, which is over 90% (Figure S5C).
5hmC Is Strand Biased toward G-Rich Sequences
The asymmetry of 5hmC in H1 suggests that, on a population
average, one strand is more likely to be hydroxymethylated
than the other strand. One possible explanation for this
phenomenon is a sequence preference of 5hmC for one strand
compared to the other. To examine this systematically, we
aligned all 5hmCs in CG context and examined base composi-
tion (Figure 6A). On the strand containing 5hmC, we observed
a modest increase in local guanine abundance with depletion
of adenine and thymine content. Within a window of 100 bp
around 5hmCs, the local sequence content of guanine
increases to an average of 29.9%, significantly higher than
the 25.6% observed for randomly sampled methylated cyto-
sines (Figure S6A, p < 1 3 1015, Wilcoxon). These observa-
tions are not a function of regulatory element class, as similartrends hold for subsets of 5hmC found at promoters, distal-
regulatory elements, and genic regions (Figure S6C). Further-
more, similar trends are observed in mESCs (Figure S6D),
and analysis of the spike-in lambda DNA shows that this
observation is not a systematic bias of the TAB-Seq method
(Figure S6B).
Our observations suggest that 5hmC deposition is biased
toward the strand with a higher local density of guanine. To
test this hypothesis, we developed a predictive algorithm: given
that a strand-biased hydroxymethylation event exists at a partic-
ular CG (p value = 0.01, Fisher’s exact test) and that one strand
has local guanine content significantly different from the other
strand (p value = 0.01, Fisher’s exact test), we predict the strand
with higher guanine content to have the hydroxymethylation
event. This model correctly predicts the hydroxymethylated
strand with 82.7% accuracy, significantly better than the 50%
expected by chance (Figure 6B, p < 1 3 1015, binomial), con-
firming that local sequence content plays a role in strand-
specific hydroxymethylation. However, although both hESCs
and mESCs exhibit a bias of 5hmCG to occur on the strand
with more guanine content (Figures S6C and S6D), the effect is
weaker in mESCs (Figures S6E and S6F), which is one potential
reason that guanine content does not predict 5hmC in mESCs.Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc. 1375
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Figure 6. Local Sequence Context around 5hmCG
(A) Sequence context ± 150 bp around 5hmCG sites (left),
compared to the same number of randomly chosen mCG sites
(right). Shown sequences are on the same strand as 5hmC. Inset:
sequence context ± 10 bp around 5hmCG sites that are on the
Watson or Crick strands. Positive coordinates indicate the 30
direction.
(B) Shown here is the frequency at which the following two events
co-occur: cytosines show significant difference in 5hmCG
between Watson and Crick strands (p = 0.01, Fisher’s exact test),
and cytosines with abundance of guanine ± 50 bp around the site
show significant strand bias (p = 0.01, Fisher’s exact test).
See also Figure S6.One possible explanation is the large difference in the expression
levels of TET1 and TET2 in hESCs and mESCs.
5hmC Is Most Enriched near Low-CpG Regions
Recent affinity-based studies in mESCs have observed 5hmC to
be frequently enriched at CpG island-containing promoters (Ficz
et al., 2011; Pastor et al., 2011;Williams et al., 2011), and that the
highest levels of 5hmC correspond to the highest density of
CpGs (Ficz et al., 2011). In contrast, an affinity-based 5hmC
map produced in H1 found 5hmC-rich regions to be depleted
of CpG dinucleotides (Szulwach et al., 2011a). These confound-
ing results prompted us to examine the relationship between
absolute steady-state 5hmC level and CpG content at
promoters. We found that promoters with the highest levels of
5hmCG are almost exclusively of low CpG content (Figure 7A)
and are also the promoters most likely to have the highest
5mCG (Figure S7A). In agreement with this observation, when
we divide promoters by CpG content, we observe that the
density of 5hmC is lowest at high-CpG promoters (HCPs),
whereas at low-CpG promoters (LCPs) and intermediate-CpG
promoters (ICPs), 5hmC is at least 3.3 times more abundant
(Figure S7H). Analyses of mESCs give similar results (Figure 7B).
In both hESCs and mESCs, CpG-rich promoters are almost
devoid of steady-state 5hmC. Moreover, these results apply to
promoters containing H3K4me3 or bivalent chromatin modifica-
tions (Figure S7G).
Considering the above together with our observation of an
increased local density of guanine on the strand of hydroxyme-
thylation, we postulated that promoters with high GC content
but low CpG density are more likely to be hydroxymethylated.
Indeed, such bivalent (p < 1 3 10300) and H3K4me3-only
promoters (p = 7.8 3 10286) are more enriched with 5hmC
(Figure 7C).1376 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.To determine whether hydroxymethylation at distal-
regulatory elements is also biased toward low CpG
density, we examined three classes of DNase I-hyper-
sensitive sites (DHSs): (1) those lacking the enhancer
histone modifications H3K4me1 and H3K27ac; (2)
putative poised enhancers bearing only H3K4me1;
and (3) putative active enhancers with both modifica-
tions (Hawkins et al., 2010; Myers et al., 2011). Poised
and active enhancers exhibit the strongest enrichment
of 5hmC (Figures 7D–7F), which almost exclusivelycorresponds to low-CpG density regions. Like promoters, the
few distal DHSs with high CpG density are generally composed
of low 5hmCG content. We also observed similar results at distal
p300-binding sites (Figures S7B and S7C). Together, these
results suggest that the highest levels of 5hmC occur at regions
of the genome with low CpG density.
Comparing DHSs lacking the H3K4me1 and H3K27ac
enhancer marks to poised enhancers having only H3K4me1,
5mCGdrops by 12.6%, and 5hmC increases by 2.7-fold (Figures
S7D–S7F). In contrast, active enhancers having both H3K4me1
and H3K27ac have 8.3% less 5mCG than poised enhancers
but with only a 1.08-fold increase in 5hmC. These results suggest
that whereas 5mCG is inversely related to both H3K4me1 and
H3K27ac, 5hmC is primarily proportional to H3K4me1.
DISCUSSION
Bisulfite sequencing has been broadly used to analyze the
genomic distribution and abundance of 5mC (Bernstein et al.,
2007; Clark et al., 1994; Lister et al., 2008; Meissner, 2010;
Pelizzola and Ecker, 2011). However, because traditional bisul-
fite sequencing cannot distinguish 5mC from 5hmC, results
from such approaches cannot yet accurately reveal 5mC abun-
dance (Huang et al., 2010; Jin et al., 2010). Recent experiments
show that 5hmC is widespread in the mammalian genome, and
at least two functions have been proposed for this cytosine
modification: (1) 5hmC serves as an intermediate in the process
of DNA demethylation, either passively (Inoue and Zhang, 2011)
or actively through further oxidation (He et al., 2011; Ito et al.,
2011; Maiti and Drohat, 2011; Zhang et al., 2012); (2) 5hmC
may be recognized by chromatin factors (Frauer et al., 2011;
Yildirim et al., 2011), and its presence could reduce binding of
certain methyl-CpG-binding proteins (Hashimoto et al., 2012;
all promoters: H1 DHS, low H3K4me1, low H3K27ac
DHS, high H3K4me1, low H3K27ac
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Figure 7. 5hmCG is Biased toward Low-
CpG Regions
(A, B, and D–F) Shown are heatmaps of percent
5hmCG (± 250 bp from TSS or DHS) as a function
of CpG density for (A) promoters in H1 ESCs, (B)
promoters in mESCs, (D) DHS sites lacking
H3K4me1 and H3K27ac, (E) DHS sites with
a poised enhancer chromatin signature, and (F)
DHS sites with an active enhancer chromatin
signature.
(C) The GC content relative to the CpG content for
the 5hmC-enriched versus the 5hmC not-enriched
promoters.
For boxplots, notches indicate median, boxes
extend to the 25th and 75th percentiles, and whis-
kers extend to nonoutliers. See also Figure S7.Kriaucionis and Heintz, 2009; Valinluck et al., 2004). These func-
tions implicate two opposing notions about the relative stability
of 5hmC at distinct genomic loci. As the first step toward under-
standing these molecular mechanisms associated with 5hmC
function, it is important to not only precisely locate 5hmC in
the genome but also determine the relative abundance at each
modified site. Here we describe a modified bisulfite sequencing
method that when combinedwith traditional bisulfite sequencing
can determine the location of 5hmC at single-base resolution
and quantitatively assess the abundance of 5mC and 5hmC at
each modified cytosine.
Using model DNA, we demonstrated that coupling bGT-
mediated protection of 5hmC with mTet1-based oxidation
of 5mC allows for the distinction of 5hmC from unmodified cyto-
sine and 5mC by sequencing. 5fC and 5caC presented in theCell 149, 1368–13original genomic DNA do not interfere
with TAB-Seq because they behave like
unmodified cytosine under bisulfite treat-
ment (He et al., 2011).We also utilized this
method to examine previously reported
5hmC-enriched loci and successfully
identified genuine 5hmC sites. These
results show the general utility of TAB-
Seq to assess 5hmC in a loci-specific
manner, much the same as how tradi-
tional bisulfite sequencing is currently
used.
We applied this technique to mamma-
lian genomes by generating single-base
resolution maps of 5hmC in hESCs and
mESCs. We show that these maps agree
well with previous maps generated with
affinity-based5hmCprofiling. Importantly,
these single-base maps also revealed
a significant number of new 5hmC sites.
Analyses of two5hmCmaps inESCs iden-
tified several unique sequence-based
characteristics of 5hmC. We observed
that, much like 5mC, 5hmC tends to occur
primarily at CpG-dinucleotides yet, unlike
5mC, exhibits an asymmetric strand bias.We also observed a relatively strong local sequence preference
surrounding 5hmC, with 5hmC occurring within a G-rich context.
This observation is consistent with a previous report that 5hmC
regions are GC skewed (Stroud et al., 2011). These sequence-
based features associated with 5hmC may provide a basis for
future mechanistic insight into the means by which 5hmC is
deposited, recognized, and dynamically regulated.
The ability to quantify 5hmC abundance with base resolution
offered the unique opportunity to assess its relative abundance
at various regulatory elements and genomic annotations without
bias. In contrast to the nearly uniform distribution of 5mC outside
of promoter regions,we found that theabundanceof 5hmCvaries
among different classes of functional sequences. It is most en-
riched at distal-regulatory regions where levels of 5mC are corre-
spondingly lower than the genome average. This observation80, June 8, 2012 ª2012 Elsevier Inc. 1377
agrees with recent findings from others (Stadler et al., 2011) and
suggests that active demethylation occurs at active regulatory
elements through 5hmC. This active demethylation is distributed
around, but not within, transcription factor consensus motifs.
Supporting the notion of active demethylation, total DNA
methylation exhibits a strong negative correlation with 5hmC at
distal-regulatory elements (Spearman correlation = 0.30). One
interesting observation of these distal cis-regulatory elements is
that 5hmC and 5mC often occur together at the same position.
Currently, the exact mechanisms that determine the dynamics
of 5hmCand 5mCat these cis-regulatory sequences are unclear.
Previous affinity-based studies have suggested enrichment of
5hmC at CpG-rich transcription start sites. However, these
observations relied heavily on antibody-based detection, which
has been shown to exhibit bias toward 5hmC-dense regions.
Here we find that, in general, 5hmC is most abundant at regions
of low CpG content. Furthermore, even promoters with relatively
high 5hmC content tend to have low CpG content in both
mESCs and hESCs. These findings highlight the utility of
a base-resolution method for measuring 5hmC abundance and
provide insight into the dynamic regulation of 5hmC at promoter
sites with distinct CpG content.
Tahiliani and colleagues (Tahiliani et al., 2009) recently esti-
mated the genome-wide abundance of 5hmC to be about 14
times less than that of 5mC, which would correspond to 4.4
million 5hmCs in human. However, as our results indicate that
the base-level abundance of 5hmC is several times lower than
that of 5mC, this is likely an underestimate. The comparatively
low number of 5hmCs confidently detected in our study
(691,414) is likely explained by the frequent hydroxymethylation
of gene bodies previously observed in affinity-based studies
(Ficz et al., 2011; Pastor et al., 2011; Stroud et al., 2011;
Szulwach et al., 2011a; Williams et al., 2011; Wu et al., 2011;
Xu et al., 2011). Because genic cytosines likely exist at a relatively
low abundance of 5hmC (3%–4%), they would have escaped
detection at our current sequencing depth. In order to resolve
low-abundance 5hmCs at single-base precision, significantly
more sequencing would be required. This observation highlights
the biases inherent in affinity-based 5hmC mapping, which can
amplify frequent weak signals found in gene bodies to over-
shadow rare but stronger ones at distal-regulatory elements.
In summary, we have developed a genome-wide approach to
determine 5hmC distribution at base resolution and have gener-
ated base-resolution maps of 5hmC in both hESCs and mESCs.
These maps provide a template for further understanding the
biological roles of 5hmC in stem cells as well as gene regulation
in general. In conjunction with methylC-Seq, the TAB-Seq
method described here represents a general approach to
measure the absolute abundance of 5mC and 5hmC at specific
sites or genome-wide, which could be widely applied to various
cell types and tissues.EXPERIMENTAL PROCEDURES
Glucosylation and Oxidation of Genomic DNA
Glucosylation reaction was performed in a 50 ml solution with 50 mM HEPES
buffer (pH 8.0), 25 mM MgCl2, 100 ng/ml sonicated genomic DNA with spike-
in control, 200 mM UDP-Glc, and 1 mM wild-type bGT. The reaction was incu-1378 Cell 149, 1368–1380, June 8, 2012 ª2012 Elsevier Inc.bated at 37C for 1 hr. After the reaction, the DNA was purified by a QIAquick
Nucleotide Removal Kit (QIAGEN). The oxidation reaction was performed in
a 50 ml solution with 50 mM HEPES buffer (pH 8.0), 100 mM ammonium iron
(II) sulfate, 1 mM a-ketoglutarate, 2 mM ascorbic acid, 2.5 mM DTT,
100mMNaCl, 1.2mMATP, 10 ng/ml glucosylated DNA, and 3 mM recombinant
mTet1. The reaction was incubated at 37C for 1.5 hr. After proteinase K treat-
ment, the DNA was purified with Micro Bio-Spin 30 Columns (Bio-Rad) and
then by a QIAquick PCR Purification Kit (QIAGEN).
Quantifying %5hmCG and %5mCG
For a given genomic interval, the abundance of hydroxymethylation (%hmCG)
is estimated as the number of cytosine base calls in the interval divided by the
number of cytosine plus thymine base calls in the interval from TAB-Seq reads,
where the reference is in CG context. To estimate %5mC level, we subtracted
the total methylation level from methylC-Seq by the %5hmC level from TAB-
Seq. In all instances, only base calls with Phred scoreR 20 were considered.
ACCESSION NUMBERS
Sequencing data have been deposited to GEO (accession number
GSE36173).
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Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
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